News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Phages, peptides and live biotherapeutics could help combat antibiotic-resistant bacteria but don’t expect heavy R&D investment until people start dying from post-operative infection, says EpiBiome.
Irvine Scientific has launched a system it claims can increase viral vector and recombinant protein production yields.
StemCells Inc has merged with Israeli medical devices firm Microbot Medical three months after terminating a Phase II trial of its HuCNS-SC human neural stem cells.